Stock listing

ZNTL Stock Price, News, Filings & Events — Zentalis Pharmaceuticals, Inc.

Selected listing: ZNTL · BOATS · USD · US

This page tracks Zentalis Pharmaceuticals, Inc.'s ZNTL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZNTL:BOATS. ZNTL:BOATS is the stock-level entry point for investors researching Zentalis Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zentalis Pharmaceuticals, Inc. is a public company traded under the ticker ZNTL in the American market. The company has a market capitalization of approximately $347.4 million. Zentalis focuses on developing innovative therapies for cancer treatment.

ZNTL:BOATSUSDUSUpdated September 11, 2026
Zentalis Pharmaceuticals, Inc. logo
Ticker
ZNTL:BOATS
Asset type
Stock
Market cap
$332.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Zentalis Pharmaceuticals, Inc. ZNTL:BOATS stock context

This page tracks Zentalis Pharmaceuticals, Inc.'s ZNTL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZNTL:BOATS. ZNTL:BOATS is the stock-level entry point for investors researching Zentalis Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zentalis Pharmaceuticals, Inc. is a public company traded under the ticker ZNTL in the American market. The company has a market capitalization of approximately $347.4 million. Zentalis focuses on developing innovative therapies for cancer treatment.

Latest news from Zentalis Pharmaceuticals, Inc.

All Zentalis Pharmaceuticals, Inc. news →

Research Zentalis Pharmaceuticals, Inc.

Alternate listings